Identification of weight loss-mediating liraglutide targets

The type 2 diabetes drug liraglutide is a glucagon-like peptide-1 receptor (GLP-1R) agonist that lowers blood glucose and reduces body weight. Liraglutide is being investigated for use as a treatment for obesity; however, the mechanism of action underlying the associated weight loss is not clear. In this episode, Lotte Bjerre Knudsen and colleagues reveal that liraglutide mediates weight loss via neurons in the arcuate nucleus. GLP-1R signaling activated centrally projecting neurons that express proopiomelanocortin and cocaine- and amphetamine-regulated transcript (POMC/CART neurons), which regulate appetite and are activated by leptin and insulin. Liraglutide also inhibited neuropeptide Y-expressing neurons, which enhance appetite. The results of this study provide important insight into how liraglutide mediates weight loss.
Video Rating: / 5

Click here to get The Okinawa Flat Belly Tonic

One thought on “Identification of weight loss-mediating liraglutide targets”
  1. Guys. lost crazy amounts of weight does not need to be hard (I used to feel it did). I'll give you some tips now. Get a popular fat burn secrets called Custokebon Secrets (google it). Thanks to it I have lost tons of weight. I should not even be talking about it cause I don't really want a bunch of other guys out there running exactly the same game but whatever. I am just simply in a great mood right now so I'll share the wealth lol.

Leave a Reply

Your email address will not be published. Required fields are marked *